☆ 4.5 Letter

A new mouse esophageal cancer cell line (mEC25)-derived pre-clinical syngeneic tumor model for immunotherapy

CANCER COMMUNICATIONS (2020)

Get Full Text
Add to Collection

Journal

CANCER COMMUNICATIONS
Volume 40, Issue 7, Pages 316-320

Publisher

WILEY
DOI: 10.1002/cac2.12066

Keywords

esophageal cancer; immunotherapy; syngeneic mouse model

Categories

Oncology

Funding

  1. National Key R&D Program of China [2017YFA0503900]
  2. National Natural Science Foundation of China [81772957]
  3. Science and Technology Program of Guangdong Province in China [2019B030301009]
  4. Industry and Information Technology Foundation of Shenzhen [20180309100135860]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.